%0 Journal Article
%T Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases
%A Albert Picado
%A Audrey Albertini
%A Byron Arana
%A Israel Cruz
%A Jose A. Ruiz-Postigo
%A Joseph M. Ndung'u
%A Mady Barbeitas
%J Archive of "Parasite Epidemiology and Control".
%D 2019
%R 10.1016/j.parepi.2019.e00103
%X Localized cutaneous leishmaniasis and its evolving forms diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans, together with the visceral leishmaniasis sequelae post-kala azar dermal leishmaniasis account for about one million dermal leishmaniases cases per year worldwide. Although not lethal, the dermal leishmaniases cause chronic and disfiguring skin lesions, which are an important cause of morbidity and stigma
%K Leishmaniasis
%K Cutaneous leishmaniasis
%K Dermal leishmaniasis
%K Point-of-care diagnostics
%K Target Product Profile
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423987/